Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
NCT01309542
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1403
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Desvenlafaxine Succinate
Sponsor
Pfizer